Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Autumn crocus extract is a botanical preparation derived from the plant *Colchicum autumnale*. Its primary active constituent is the alkaloid colchicine, which exerts potent anti-inflammatory effects by binding to tubulin and inhibiting microtubule polymerization. This action disrupts leucocyte chemotaxis, degranulation, and phagocytosis. In the context of cardiovascular medicine, researchers at Gentofte Hospital and other institutions have investigated the use of colchicine-containing preparations for the prevention and treatment of atrial fibrillation and atrial flutter, particularly following cardiac surgery. The rationale is that by mitigating the local and systemic inflammatory response associated with surgical trauma or underlying cardiac conditions, the extract can reduce the incidence of arrhythmia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on autumn crocus extract.